Results 121 to 130 of about 3,130,322 (229)

Impact of tumor cytoreduction in metastatic prostate cancer

, 2019
Yaya Sow, Ousmane Sow, Boubacar Fall, Babacar Sine, Alioune Sarr, Cyrille Zé Ondo, Babacar Diao, Alain Khassim Ndoye, Mamadou BaUrology and Andrology Department at Aristide Le Dantec Hospital, Cheikh Anta Diop University, Dakar, SenegalObjective ...
Sow Y, Fall B, Sarr A, Sine B, Ba M, Ndoye AK, Zé Ondo C, Diao B, Sow O   +8 more
core  

Surgical procedures.

, 2019
Surgical procedures.
Richard Anderson (814737), Robert A. Peterfreund (6837095), Hao Deng (409186), Timothy T. Houle (5438318), Jean-Valery Coumans (309376)   +4 more
core   +1 more source

Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.

, 1993
PURPOSE This study was undertaken to assess the ability of computed tomography (CT) to predict the likelihood of optimal primary tumor cytoreduction in women with epithelial ovarian carcinoma. PATIENTS AND METHODS Fifty-one women with preoperative CT and
P E Schwartz, A T Rosenfield, B E Nelson
core   +1 more source

Role of cytoreduction in stage III and IV uterine papillary serous carcinoma.

, 2007
OBJECTIVE: Uterine papillary serous carcinoma (UPSC) frequently presents in advanced stages. The aim of this study was to assess the role of cytoreduction in stage IIIC-IV UPSC.
Keeney, Gary L, Dowdy, Sean C, Mariani, Andrea, Podratz, Karl C, Cliby, William A, Thomas, M Bijoy, MD   +5 more
core   +1 more source

Preoperative predictors that impact the survival and outcome of patients undergoing secondary cytoreduction for ovarian cancer

, 2018
This study aimed to examine the factors affecting feasibility of optimal and complete secondary cytoreductive surgery (SCRS) and to characterise the prognostic factors that correlate with improved survival in patients who underwent SCRS.
Wei-Ting Hwang, Emin Tahirovic, Janos L. Tanyi, Stephen C. Rubin, Marina Katsnelson   +4 more
core   +1 more source

A proposal of Brazilian Society of Surgical Oncology for standardizing cytoreductive surgery plus hypertermic intraperitoneal chemotherapy procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma

Revista do Colégio Brasileiro de Cirurgiões
ABSTRACT Cytoreductive surgery plus hypertermic intraperitoneal chemotherapy has emerged as a major comprehensive treatment of peritoneal malignancies and is currently the standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome as well as malignant peritoneal mesothelioma.
Thales Paulo Batista, Bruno José Queiroz Sarmento, Janina Ferreira Loureiro, Andrea Petruzziello, Ademar Lopes, Cassio Cortez Santos, Cláudio de Almeida Quadros, Eduardo Hiroshi Akaishi, Eduardo Zanella Cordeiro, Felipe José Fernández Coimbra, Gustavo Andreazza Laporte, Leonaldson Santos Castro, Ranyell Matheus Spencer Sobreira Batista, Samuel Aguiar Júnior, Wilson Luiz Costa Júnior, Fábio Oliveira Ferreira   +15 more
openaire   +1 more source

Quality Improvement in the Surgical Approach to Advanced Ovarian Cancer: The Mayo Clinic Experience

, 2009
Background: After observing disparate rates of cytoreduction, we initiated efforts to improve outcomes through feedback and education, and we reassessed outcomes.
Jones, Monica B., Podratz, Karl C., Stanhope, Robert C., Aletti, Giovanni D., Gostout, Bobbie S., Cliby, William A., Wilson, Timothy O., Dowdy, Sean C.   +7 more
core   +1 more source

A Review of Thoracic and Mediastinal Cytoreductive Techniques in Advanced Ovarian Cancer: Extending the Boundaries

, 2017
The aim of this study was to review the surgical and clinical outcomes of intrathoracic and mediastinal surgical cytoreduction in stage IV epithelial ovarian cancer (EOC). Relevant articles were identified from MEDLINE and EMBASE.
Bristow, R., Haidopoulos, D., Kyrgiou, M., Nasser, S., Fotopoulou, C., Krell, J.   +5 more
core   +1 more source

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei

, 2005
Background and aims: Surgical improvement can be achieved in selected patients with pseudomyxoma peritonei (PMP) by major cytoreductive surgery and intraperitoneal chemotherapy (IPEC).
Z. G�ner, Schmidt, U., Dahlke, M. H., M. H. Dahlke, G�ner, Z., U. Schmidt, Schlitt, H. J., J. Klempnauer, H. J. Schlitt, P. Piso, Piso, P., Klempnauer, J.   +11 more
core   +1 more source

Challenges in evaluating surgical innovation [PDF]

, 2009
Research on surgical interventions is associated with several methodological and practical challenges of which few, if any, apply only to surgery. However, surgical evaluation is especially demanding because many of these challenges coincide.
Ergina, Patrick L, Seiler, Christoph M, Boutron, Isabelle, Blazeby, Jane M, Cook, Jonathan Alistair, Clavein, Pierre-Alain, Reeves, Barnaby C   +6 more
core